No. | Document Title | ID | Updated | Views |
---|---|---|---|---|
321 | Modalities | 101818 | 2022-12-02 | 422 |
322 | Arm Description | 101817 | 2022-12-02 | 566 |
323 | Arm Code | 101816 | 2022-12-02 | 438 |
324 | Arm | 101815 | 2022-12-02 | 482 |
325 | Step Type | 101814 | 2022-12-02 | 348 |
326 | Step | 101813 | 2022-12-02 | 357 |
327 | Exempt (if applicable) | 101811 | 2022-12-02 | 335 |
328 | Expanded Access Status | 101810 | 2022-12-02 | 350 |
329 | Expanded Access | 101809 | 2022-12-02 | 373 |
330 | IND/IDE: Expiration Date | 101807 | 2022-12-02 | 361 |
331 | FDA Approval Date | 101806 | 2022-12-02 | 387 |
332 | IND/IDE Submit Date | 101805 | 2022-12-02 | 316 |
333 | Grantor | 101804 | 2022-12-02 | 313 |
334 | NCI/NIH Institution | 101803 | 2022-12-02 | 329 |
335 | Investigational Drug/Device | 101800 | 2022-12-02 | 326 |
336 | Fund Account No. | 101797 | 2022-11-29 | 488 |
337 | Sponsor Protocol No. | 101796 | 2022-11-29 | 353 |
338 | Sponsor Type | 101795 | 2022-11-29 | 400 |
339 | Managment Group | 101788 | 2022-11-29 | 395 |
340 | Toxicity Scheme | 24235 | 2022-11-25 | 487 |
Not finding what you are looking for? Suggest a new document be created, or try searching again with multiple search terms.